Dow Up 2.00% Nasdaq Up 1.66%

Novogen Limited (NVGN)

-NasdaqCM
1.83 Down 0.02(1.08%) Feb 12, 3:59PM EST
Prev Close:1.85
Open:1.88
Bid:N/A
Ask:3.21 x 400
1y Target Est:5.00
Beta:0.151415
Next Earnings Date:N/A
Day's Range:1.79 - 1.85
52wk Range:1.79 - 9.50
Volume:33,155
Avg Vol (3m):47,700
Market Cap:30.97M
P/E (ttm):N/A
EPS (ttm):-0.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):25.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :-0.02
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novogen Limited engages in the pharmaceutical research and development business in Australia. The company primarily has two drug technology platforms, which include superbenzopyran (SBPs) and anti-tropomyosin (ATMs). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback